These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 15567770)
1. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia]. Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Pae CU; Yoon CH; Kim TS; Kim JJ; Park SH; Lee CU; Lee SJ; Lee C; Paik IH Int Immunopharmacol; 2006 Apr; 6(4):666-71. PubMed ID: 16504930 [TBL] [Abstract][Full Text] [Related]
3. Effects of antipsychotics on the serum BDNF levels in schizophrenia. Chen CC; Huang TL Psychiatry Res; 2011 Oct; 189(3):327-30. PubMed ID: 21320726 [TBL] [Abstract][Full Text] [Related]
4. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients. Singh B; Bera NK; Nayak CR; Chaudhuri TK Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081 [TBL] [Abstract][Full Text] [Related]
5. The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Song XQ; Lv LX; Li WQ; Hao YH; Zhao JP Biol Psychiatry; 2009 Mar; 65(6):481-8. PubMed ID: 19058794 [TBL] [Abstract][Full Text] [Related]
6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
7. Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine. Ajami A; Abedian F; Hamzeh Hosseini S; Akbarian E; Alizadeh-Navaei R; Taghipour M Iran J Immunol; 2014 Sep; 11(3):200-9. PubMed ID: 25265997 [TBL] [Abstract][Full Text] [Related]
8. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia. Flynn SW; MacEwan GW; Altman S; Kopala LC; Fredrikson DH; Smith GN; Honer WG Pharmacopsychiatry; 1998 Jan; 31(1):25-9. PubMed ID: 9524981 [TBL] [Abstract][Full Text] [Related]
9. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis]. Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Zink M; Kuwilsky A; Krumm B; Dressing H J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423 [TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977 [TBL] [Abstract][Full Text] [Related]
12. [Studies on the relationship between the level of cytokine and liver function in patients with clonorchiasis sinensis]. Cai LS; Xiao JY; Xin H; Zhu LX; Chen G; Zhang T; Wang GZ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):54-6. PubMed ID: 15283270 [TBL] [Abstract][Full Text] [Related]
13. Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients. Kamińska T; Wysocka A; Marmurowska-Michalowska H; Dubas-Slemp H; Kandefer-Szerszeń M Arch Immunol Ther Exp (Warsz); 2001; 49(6):439-45. PubMed ID: 11814238 [TBL] [Abstract][Full Text] [Related]
15. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269 [TBL] [Abstract][Full Text] [Related]
16. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients. Sirota P; Meiman M; Herschko R; Bessler H Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416 [TBL] [Abstract][Full Text] [Related]
17. COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. Müller N; Ulmschneider M; Scheppach C; Schwarz MJ; Ackenheil M; Möller HJ; Gruber R; Riedel M Eur Arch Psychiatry Clin Neurosci; 2004 Feb; 254(1):14-22. PubMed ID: 14991374 [TBL] [Abstract][Full Text] [Related]
18. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia. Kim JH; Kim SY; Ahn YM; Kim YS Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807 [TBL] [Abstract][Full Text] [Related]
19. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Gross A; Joutsiniemi SL; Rimon R; Appelberg B Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895 [TBL] [Abstract][Full Text] [Related]
20. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients. Kim YK; Myint AM; Verkerk R; Scharpe S; Steinbusch H; Leonard B Neuropsychobiology; 2009; 59(2):123-9. PubMed ID: 19390223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]